According to the latest market report published by Credence Research,
Inc. “Peptic Ulcer Drugs Market – Growth, Future Prospects and
Competitive Analysis, 2017 – 2025” the global Peptic ulcer drugs market
was valued at US$ 4.63 Bn in 2016, and is expected to reach US$ 5.92 Bn
by 2025, expanding at a CAGR of 2.8% from 2017 to 2025.
Browse the full report Peptic Ulcer Drugs Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 at http://www.credenceresearch.com/report/peptic-ulcer-drugs-market
Market Insights
A
peptic ulcer is forms of painful sores that develops on the mucosal
lining of the stomach, small intestine or lower esophagus, mainly caused
by Helicobacter pylori infection and long-term use of aspirin and
certain other painkillers. For the purpose of study peptic ulcer drugs
market is segmented on the basis of drug class such as antibiotics,
proton pump inhibitors (PPIs), H2 receptor antagonists, gastric mucosal
protective drugs, antacids and prostaglandin agonists. It is observed
that currently, PPIs is major revenue generating segment because these
drugs are recommended as a first line treatment for treatment of peptic
ulcers caused by H. pylori bacterial infection and NSAIDs, due to its
ability to reduce acid secretion. It is studied that, in the base year
2016, North America dominated the peptic ulcer drugs market in terms of
revenue and it is anticipated that it will show steady growth during
forecast period. According to Centers for Disease Control and Prevention
(CDC) peptic ulcer affects more than 6 million population in the United
States annually. Factors such as large number of affected population,
higher cost of treatment medication, improved diagnostic technique and
upsurge in funding by the government agencies in healthcare system are
driving the market growth in North America. On the other hand, Asia
Pacific will show highest growth rate during forecast period due to
changing lifestyle, higher number of affected population, increasing
rate of smoking and rising healthcare awareness would expected to drive
growth of peptic ulcers drugs market globally.
Peptic Ulcer Drugs Market
Market Competition Assessment:
The
peptic ulcer drugs market is observed to be highly competitive and
comprises large number of players. However, the market is currently
dominated by few players such as Abbott Laboratories, AstraZeneca plc,
Cadila Healthcare Ltd, Daewoong Pharmaceuticals, Eisai Co. Ltd,
PharmaKing Co. Ltd, Taiho Pharmaceutical (A Otsuka Holdings), Takeda
Pharmaceutical, Yuhan Corporation and other.
Key Market Movements:
–
Factors such as increase in number of target population, improved
diagnostic techniques, easy availability of treatment medication,
preferable use of peptic ulcer medication over surgery and over use of
painkiller medications are driving the growth of peptic ulcer drugs
market globally.
– Furthermore change in lifestyle such as
stress, diet, increase in rate of smocking would assist growth of peptic
ulcer drugs market.
– However, wide availability of generic
medication, poor patient compliance to medication in some countries and
adverse effects associated with the use of medication which would
negatively impacting market growth of peptic ulcer drugs.
About Credence Research:
Credence
Research is a worldwide market research and counseling firm that serves
driving organizations, governments, non legislative associations, and
not-for-benefits. We offer our customers some assistance with making
enduring enhancements to their execution and understand their most
imperative objectives. Over almost a century, we’ve manufactured a firm
extraordinarily prepared to this task.
For More Information, Visit: http://www.credenceresearch.com/
Media Contact
Company Name: Credence Research
Contact Person: Chris Smith,
Designation: Global Sales Manager
Phone: +1-800-361-8290 (Toll FREE)
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103
E-mail: sales@credenceresearch.com
